Ozempic (semaglutide) is a once-weekly injectable medication that has transformed weight management and type 2 diabetes treatment since its widespread adoption in the early 2020s. By 2026, it remains one of the most prescribed GLP-1 receptor agonists globally, approved in the United States, United Kingdom, Germany, Japan, China, Canada, France, Netherlands, Switzerland, Australia, Dubai (UAE), […]